MAI network supplier
제약 CRO/CMO
등록 후 이용 가능 위치
이러한 시설은 기본 기준과 일치하지만 모든 선택적 필터와 일치하지는 않습니다.
Markets: DIGEMID (Peru), ANMAT (Argentina), Turkish Health Authorities, EDE (UAE), 나머지 세계, ANVISA (Brazil), ISP (Chile), PMDA (Japan), FDA (USA), MSPAS (Guatemala), CDSCO (India), Russian Health Authorities, EMA (EU), COFEPRIS (Mexico), MFDS (South Korea), SFDA (Saudi Arabia), TGA (Australia), NMPA (China), Health Canada (Canada), INVIMA (Colombia), MHRA (UK)
Batch Size: Small, Medium, Large
Category / Product: FDF / DRUG PRODUCTS
Compliance: EMA (EU GMP), ANVISA (Brazil B-GMP), TGA (Australia GMP), FDA (cGMP), ECOVADIS, ISO, Health Canada (Canada GMP), MFDS/KFDA (Republic of Korea GMP)
Controlled Substances: Lowest potential for abuse
BSL (Biological Safety Level): 3, 1, 2
Use: Human, Veterinary
Services: Analytical / QC services, Logistics, Manufacturing services, Regulatory services, Development services, Packaging, Quality Assurance services
OEB (Occupational Exposure Banding): 2 (PDE = 1,000 - 5,000 µg/day), 4 / HPAPI (PDE = 10 - 100 µg/day), 1 / low-hazard (PDE > 5,000 µg/day), 3 (PDE = 100 - 1,000 µg/day)
Region: North America

Adare Pharma Solutions
Adare Pharma es un CDMO 글로벌 설치는 EE.UU에 있습니다. y la UE, que ofrece desarrollo de productos llave en mano mediante experiencia en fabricación camerci
Markets: DIGEMID (Peru), ANMAT (Argentina), EDE (UAE), ANVISA (Brazil), ISP (Chile), PMDA (Japan), FDA (USA), MSPAS (Guatemala), Russian Health Authorities, EMA (EU), COFEPRIS (Mexico), MFDS (South Korea), SFDA (Saudi Arabia), TGA (Australia), NMPA (China), Health Canada (Canada), INVIMA (Colombia), MHRA (UK)
Batch Size: Small, Medium, Large
Category / Product: FDF / DRUG PRODUCTS, SERVICES, PARTICLE ENGINEERING
Compliance: EMA (EU GMP), PMDA/MHLW (Japan GMP), UAE Ministry of Health & Prevention, ANVISA (Brazil B-GMP), World Health Organization (GMP / HACCP), MHRA (UK GMP), French Service-Public (CIR), TGA (Australia GMP), FDA (cGMP), NMPA (China GMP), ECOVADIS, ISO, Halal Research Council, Health Canada (Canada GMP), TITCK (Turkish Health Authorities), MFDS/KFDA (Republic of Korea GMP)
Use: Human, Veterinary
Services: Analytical / QC services, Logistics, Manufacturing services, Regulatory services, Development services, Packaging, Quality Assurance services
OEB (Occupational Exposure Banding): 2 (PDE = 1,000 - 5,000 µg/day), 4 / HPAPI (PDE = 10 - 100 µg/day), 1 / low-hazard (PDE > 5,000 µg/day), 3 (PDE = 100 - 1,000 µg/day)
Region: North America
Therapeutic Areas of Expertise (ATC): (C) Cardiovascular system, (A) Digestive tract and metabolism
Batch Size: Small, Medium, Large
Use: Human
Services: Logistics, Manufacturing services, Packaging
Region: North America
Markets: FDA (USA), Health Canada (Canada)
Compliance: FDA (cGMP), NSF, Halal Research Council, Health Canada (Canada GMP)
Category / Product: NUTRACEUTICALS
MAI network supplier
재조합 단백질과 단클론 항체(mAbs)에 중점을 둔 CDMO(계약 개발 및 제조 조직)입니다.
등록 후 이용 가능 위치
MAI network supplier
고급 무균 및 비무균 의약품 제조, 제제 개발 및 분석 테스트를 위한 신뢰할 수 있는 GMP CDMO입니다.
등록 후 이용 가능 위치
MAI network supplier
상업용 API 소분자 합성.
등록 후 이용 가능 위치
MAI network supplier
Lannett의 주요 제조 현장은 인디애나주 시모어에 위치하고 있으며 OSD(경구 고형량) 및 액체 제품을 위한 기능을 갖추고 있습니다.
등록 후 이용 가능 위치
MAI network supplier
An ISO9001 Certified Supplier of Pharmaceutical Ingredients and Specialty Chemicals
등록 후 이용 가능 위치
MAI network supplier
CD Formulation은 선도적인 부형제 제조업체로서 제약 산업에 서비스를 제공하여 제품 성능을 개선하는 데 도움을 줍니다.
등록 후 이용 가능 위치
MAI network supplier
—
등록 후 이용 가능 위치
MAI network supplier
Creative Biostructure는 구조 생물학과 막 단백질 연구에 중점을 두고 설립되었습니다.
등록 후 이용 가능 위치
Are you a pharmaceutical company seeking a reliable CMO or CDMO partner to accelerate your drug development process? Look no further than MAI CDMO Network. Our advanced search platform connects you with a vast network of qualified contract manufacturers and development organizations worldwide.
Why Choose MAI CDMO Network?
How MAI CDMO Network Works
Key Benefits of Partnering with a CMO/CDMO
Featured Services
Ready to Find Your Ideal CMO/CDMO Partner? Register Now
Explore our platform today and discover how MAI CDMO Network can help you achieve your drug development goals.